Sofalcone
Chemical compound
- none
- In general: ℞ (Prescription only)
- [5-[(3-Methylbut-2-en-1-yl)oxy]-2-((2E)-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}prop-2-enoyl)phenoxy]acetic acid
- 153175-87-2 Y
- 5282219
- 4445402 N
- 2B668TJX8E
- D01956 Y
- CHEBI:135732
- DTXSID50860797 DTXSID5023586, DTXSID50860797
- Interactive image
- CC(=CCOC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C
InChI
- InChI=1S/C27H30O6/c1-19(2)13-15-31-22-8-5-21(6-9-22)7-12-25(28)24-11-10-23(32-16-14-20(3)4)17-26(24)33-18-27(29)30/h5-14,17H,15-16,18H2,1-4H3,(H,29,30)/b12-7+ N
- Key:GFWRVVCDTLRWPK-KPKJPENVSA-N N
Sofalcone (INN) is an oral gastrointestinal medication used in Japan.[1] It is a synthetic analog of sophoradin,[2] a type of natural phenol found in Sophora tonkinensis, an herb used in traditional Chinese medicine.
References
- v
- t
- e
analogues ("-prost-")
("-prazole")
acid blockers ("-prazan")
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
- See also: Helicobacter pylori eradication protocols
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e